BCR and metastatic malignant neoplasm in the lymph nodes: We also examined the incidence of BCR in cases with EPE, seminal vesicle invasion, or lymph node metastasis, which were 17/67 (25.4%), 8/16 (50%), and 9/16 (56.3%), respectively.